Curocell Inc

372320

Company Profile

  • Business description

    Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

  • Contact

    11, Gukjegwahak 16-ro
    Yuseong-gu
    Daejeon34002
    KOR

    T: +82 428633698

    https://www.curocellbtx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    140

Stocks News & Analysis

stocks

Earnings up but shares overvalued for ASX gold miner

Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks

Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%

We see faster cloud growth and improved longer-term profitability for Alphabet.
stocks

Overvalued ASX mining giant

Solid start to 2026 but shares overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,351.904.90-0.05%
CAC 408,230.414.780.06%
DAX 4024,258.6218.730.08%
Dow JONES (US)47,444.97237.850.50%
FTSE 1009,635.5610.06-0.10%
HKSE26,433.70273.551.05%
NASDAQ23,566.29361.421.56%
Nikkei 22550,512.321,212.672.46%
NZX 50 Index13,391.5914.490.11%
S&P 5006,854.6162.920.93%
S&P/ASX 2009,055.602.20-0.02%
SSE Composite Index3,996.9446.631.18%

Market Movers